Brian A. Markison - Nov 4, 2021 Form 4 Insider Report for Osmotica Pharmaceuticals plc (RVLP)

Signature
/s/ Christopher Klein, as attorney-in-fact
Stock symbol
RVLP
Transactions as of
Nov 4, 2021
Transactions value $
$0
Form type
4
Date filed
11/8/2021, 03:05 PM
Previous filing
May 12, 2021
Next filing
May 12, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the ordinary shares underlying the award on the first anniversary of the grant and as to the remaining 75% of the shares in thirty-six (36) equal monthly installments thereafter.